FY2025 EPS Estimates for Henry Schein Lowered by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Leerink Partnrs cut their FY2025 earnings per share estimates for shares of Henry Schein in a note issued to investors on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $5.20 for the year, down from their prior estimate of $5.31. The consensus estimate for Henry Schein’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $5.67 EPS and FY2027 earnings at $6.22 EPS.

A number of other research firms have also recently weighed in on HSIC. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. UBS Group decreased their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $77.50.

Henry Schein Stock Down 2.1 %

HSIC opened at $68.00 on Friday. The company has a fifty day moving average of $70.51 and a two-hundred day moving average of $69.75. The stock has a market capitalization of $8.62 billion, a price-to-earnings ratio of 27.98, a PEG ratio of 2.00 and a beta of 0.87. Henry Schein has a fifty-two week low of $62.12 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period last year, the business earned $1.32 earnings per share. Henry Schein’s quarterly revenue was up .4% on a year-over-year basis.

Hedge Funds Weigh In On Henry Schein

Institutional investors and hedge funds have recently bought and sold shares of the company. UniSuper Management Pty Ltd raised its position in shares of Henry Schein by 611.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock valued at $1,034,000 after buying an additional 11,771 shares during the period. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Henry Schein by 64.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares during the last quarter. Thompson Siegel & Walmsley LLC purchased a new position in shares of Henry Schein during the 2nd quarter worth $46,683,000. Nordea Investment Management AB increased its position in shares of Henry Schein by 8.9% during the 1st quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after purchasing an additional 798 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in Henry Schein by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after buying an additional 260,537 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.